egrettherapeutics.com | Egret Therapeutics - Targeting inflammation to boldly transform the lives of patients with severe

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: /wp-admin/admin-ajax.php Disallow: /wp-admin/ Sitemap: https://egrettherapeutics.com/sitemap.xml Sitemap:

Meta Tags

Title	Egret Therapeutics - Targeting inflammation to boldly transform the lives of patients with severe
Description	Science-driven and Targeting inflammation to boldly transform the lives of patients with severe neurological
Keywords	N/A

Server Information

WebSite	egrettherapeutics.com
Host IP	141.193.213.20
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

egrettherapeutics.com Valuation

US$2,404,692

Last updated: 2023-05-16 23:57:01

egrettherapeutics.com has Semrush global rank of 4,401,523. egrettherapeutics.com has an estimated worth of US$ 2,404,692, based on its estimated Ads revenue. egrettherapeutics.com receives approximately 277,465 unique visitors each day. Its web server is located in United States, with IP address 141.193.213.20. According to SiteAdvisor, egrettherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,404,692
Daily Ads Revenue	US$2,220
Monthly Ads Revenue	US$66,592
Yearly Ads Revenue	US$799,098
Daily Unique Visitors	18,498
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
egrettherapeutics.com.	A	3599	IP: 141.193.213.20
egrettherapeutics.com.	A	3599	IP: 141.193.213.21
egrettherapeutics.com.	NS	21600	NS Record: ns-cloud-d1.googledomains.com.
egrettherapeutics.com.	NS	21600	NS Record: ns-cloud-d2.googledomains.com.
egrettherapeutics.com.	NS	21600	NS Record: ns-cloud-d3.googledomains.com.
egrettherapeutics.com.	NS	21600	NS Record: ns-cloud-d4.googledomains.com.
egrettherapeutics.com.	MX	3600	MX Record: 1 aspmx.l.google.com.
egrettherapeutics.com.	MX	3600	MX Record: 10 alt3.aspmx.l.google.com.
egrettherapeutics.com.	MX	3600	MX Record: 5 alt1.aspmx.l.google.com.
egrettherapeutics.com.	MX	3600	MX Record: 10 alt4.aspmx.l.google.com.
egrettherapeutics.com.	MX	3600	MX Record: 5 alt2.aspmx.l.google.com.
egrettherapeutics.com.	TXT	3600	TXT Record: v=spf1 include:_spf.google.com ~all
egrettherapeutics.com.	TXT	3600	TXT Record: google-site-verification=2lg5N4XybJMHSEi4ZqkJPn5q48_kmX4n9V3roV1F2qo
egrettherapeutics.com.	TXT	3600	TXT Record: google-site-verification=BRQf3UXak2RnOViiCiMPQCHUXoGiW0YabeHsiugPvnU

HtmlToTextCheckTime:2023-05-16 23:57:01

Pipeline Team Contact News Menu Pipeline Team Contact News Science-driven and patient-focused Targeting inflammation to boldly transform the lives of patients with severe neurological diseases Pipeline Our product pipeline and areas of focus Product Indication Pre-Clinical Phase 1/2 Phase 3 NDA EGT 101 Delayed cerebral ischemia (DCI) after brain aneurysm Egret therapeutics Ischemic stroke Egret therapeutics EGT 102 Glioblastoma Egret therapeutics Brain metastasis Egret therapeutics EGT 101 Using immune regulating pathways to reduce permanent brain aneurysm damage Research shows that the same highly specific and powerful immune regulating pathways used by tumors can be leveraged to prevent DCI by precisely targeting the responsible inflammatory cells. Team Visionary leadership with deep experience in research and drug development Leadership Dan Chai, MD Chief Executive Officer Chris Jackson, MD Co-Founder & Chief Medical Officer PRIYA JAMBHEKAR, PhD Chief Regulatory Officer XIAOBU

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 23 Feb 2022 10:32:15 GMT
Content-Type: text/html
Connection: keep-alive
Location: https://egrettherapeutics.com/
CF-Cache-Status: DYNAMIC
Server: cloudflare
CF-RAY: 6e1fca098e54695b-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

HTTP/2 200 
date: Wed, 23 Feb 2022 10:32:16 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 2
x-cache-group: normal
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 6e1fca0ba8a88fdd-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

egrettherapeutics.com Whois Information

Domain Name: EGRETTHERAPEUTICS.COM
Registry Domain ID: 2652919059_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.google.com
Registrar URL: http://domains.google.com
Updated Date: 2021-11-05T20:49:15Z
Creation Date: 2021-11-05T20:49:11Z
Registry Expiry Date: 2022-11-05T20:49:11Z
Registrar: Google LLC
Registrar IANA ID: 895
Registrar Abuse Contact Email: registrar-abuse@google.com
Registrar Abuse Contact Phone: +1.8772376466
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-CLOUD-D1.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D2.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D3.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-D4.GOOGLEDOMAINS.COM
DNSSEC: signedDelegation
DNSSEC DS Data: 24131 8 2 02DE4E67002AFFE14FCCC15941868BA6E7CABEA534AB41D557F5BE64C62DECAB
>>> Last update of whois database: 2022-02-23T10:59:12Z <<<

egrettherapeutics.com valuation and analysis